Literature DB >> 25286087

Episcleral infantile hemangioma successfully treated with topical timolol.

Cristina Ciudad Blanco1, Minia Campos Domínguez, Basilio Moreno García, Cándida Ana Villanueva Álvarez-Santullano, Beatriz Berenguer Fröhner, Ricardo Suárez Fernández.   

Abstract

Episcleral hemangiomas are usually associated with neonatal hemangiomatosis. Recently, propranolol has been described for the treatment of this entity. We present for the first time a patient with an episcleral hemangioma without neonatal hemangiomatosis successfully treated with topical timolol.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  episcleral hemangioma; infantile hemangioma; topical timolol

Mesh：

Substances：

Year:  2014        PMID： 25286087     DOI： 10.1111/dth.12173

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN： 1396-0296            Impact factor:   2.851


  4 in total

1.  Efficacy of low-dose 90Sr-90Y therapy combined with topical application of 0.5% timolol maleate solution for the treatment of superficial infantile hemangiomas.

Authors:  Hong-Jian Zhu; Qinghong Liu; Xiao-Li Deng; Yan-Xing Guan
Journal:  Exp Ther Med       Date:  2015-07-01       Impact factor: 2.447

2.  Beta Blockers in the Treatment of Periocular Infantile Hemangiomas: A Review.

Authors:  Ann Q Tran; Catherine J Choi; Sara T Wester
Journal:  Intern Med Rev (Wash D C)       Date:  2016-10

3.  Topical Timolol Inhibits Corneal Neovascularization in Rabbits.

Authors:  Ali Kasiri; Mehdi Reza Ghomi; Mostafa Feghhi; Fereydoun Farrahi; Mohammad Sadegh Mirdehghan; Hesam Hedayati
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2017

4.  Role of topical beta blockers in regression of infantile capillary hemangioma.

Authors:  Murtaza Sameen Junejo; Maria Nazish Memon; Sajida Parveen Shaikh
Journal:  Pak J Med Sci       Date:  2021 Nov-Dec       Impact factor: 1.088
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.